Danny Griffin is a biotech entrepreneur and venture fellow with 11 years of experience translating academic immunoengineering and drug delivery research into clinical and commercial ventures. He co-founded Exodus Biosciences during his PhD—winning the Argersinger Prize for his thesis—and now builds early-stage companies at BioGenerator Ventures while co-founding clinical-stage firms Kinimmune and leading BD at Bond Biosciences. His work spans antigen delivery, biomaterials for rare blood biomarker capture, protein production, and high-throughput sequencing, with a track record of securing nondilutive funding and enabling NIH clinical evaluation. Based in Missouri, he combines hands-on translational science with startup fundraising and business development, bridging discovery and development to accelerate patient-facing solutions. An unexpected throughline: he leverages entrepreneurial training from the Madison and Lila Self Fellowship to found companies while still a graduate student, demonstrating an uncommon blend of deep technical rigor and early-stage company-building.
11 years of coding experience
4 years of employment as a software developer
University of Kansas
Bachelor’s Degree, Biomedical Engineering, Bachelor’s Degree, Biomedical Engineering at Widener University
Contributions:16 commits, 11 pushes, 1 branch in 1 year 3 months
Find and Hire Top DevelopersWe’ve analyzed the programming source code of over 60 million software developers on GitHub and scored them by 50,000 skills. Sign-up on Prog,AI to search for software developers.